These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 33972403)

  • 1. Cross-sectional assessment of haemostatic profile and hepatic dysfunction in Fontan patients.
    Daems JJN; Attard C; Van Den Helm S; Breur J; D'Udekem Y; du Plessis K; Wilson TG; Winlaw D; Gentles TL; Monagle P; Ignjatovic V
    Open Heart; 2021 May; 8(1):. PubMed ID: 33972403
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatic and renal end-organ damage in the Fontan circulation: A report from the Australian and New Zealand Fontan Registry.
    Wilson TG; d'Udekem Y; Winlaw DS; Cordina RL; Celermajer DS; Wheaton GR; Bullock A; Gentles TL; Weintraub RG; Justo RN; Grigg LE; Radford DJ; Hardikar W; Cheung M; Cain TM; Rao P; Alexander SI; Ayer J; Verrall C; Du Plessis K; Chapman J; Rice K; Barry J; Zannino D; Iyengar AJ;
    Int J Cardiol; 2018 Dec; 273():100-107. PubMed ID: 30060970
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MELD-XI score and cardiac mortality or transplantation in patients after Fontan surgery.
    Assenza GE; Graham DA; Landzberg MJ; Valente AM; Singh MN; Bashir A; Fernandes S; Mortele KJ; Ukomadu C; Volpe M; Wu F
    Heart; 2013 Apr; 99(7):491-6. PubMed ID: 23406689
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A composite noninvasive index correlates with liver fibrosis scores in post-Fontan patients: Preliminary findings.
    Evans WN; Acherman RJ; Ciccolo ML; Carrillo SA; Galindo A; Rothman A; Mayman GA; Adams EA; Reardon LC; Winn BJ; Yumiaco NS; Shimuizu L; Inanaga Y; Deleon RJ; Restrepo H
    Congenit Heart Dis; 2018 Jan; 13(1):38-45. PubMed ID: 29194972
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical Outcomes in Adolescents and Adults After the Fontan Procedure.
    Dennis M; Zannino D; du Plessis K; Bullock A; Disney PJS; Radford DJ; Hornung T; Grigg L; Cordina R; d'Udekem Y; Celermajer DS
    J Am Coll Cardiol; 2018 Mar; 71(9):1009-1017. PubMed ID: 29495980
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatic dysfunction following the Fontan procedure.
    Narkewicz MR; Sondheimer HM; Ziegler JW; Otanni Y; Lorts A; Shaffer EM; Horgan JG; Sokol RJ
    J Pediatr Gastroenterol Nutr; 2003 Mar; 36(3):352-7. PubMed ID: 12604973
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Forns Index is a predictor of cardiopulmonary bypass time and outcomes in Fontan conversion.
    Izumi G; Takeda A; Yamazawa H; Sasaki O; Kato N; Asai H; Tachibana T; Matsui Y
    Heart Vessels; 2020 Apr; 35(4):586-592. PubMed ID: 31562553
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Australia and New Zealand Fontan Registry: description and initial results from the first population-based Fontan registry.
    Iyengar AJ; Winlaw DS; Galati JC; Gentles TL; Weintraub RG; Justo RN; Wheaton GR; Bullock A; Celermajer DS; d'Udekem Y
    Intern Med J; 2014 Feb; 44(2):148-55. PubMed ID: 24393144
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Liver health in adults with Fontan circulation: A multicenter cross-sectional study.
    Wu FM; Kogon B; Earing MG; Aboulhosn JA; Broberg CS; John AS; Harmon A; Sainani NI; Hill AJ; Odze RD; Johncilla ME; Ukomadu C; Gauvreau K; Valente AM; Landzberg MJ;
    J Thorac Cardiovasc Surg; 2017 Mar; 153(3):656-664. PubMed ID: 27955914
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Three decades later: The fate of the population of patients who underwent the Atriopulmonary Fontan procedure.
    Poh CL; Zannino D; Weintraub RG; Winlaw DS; Grigg LE; Cordina R; Hornung T; Bullock A; Justo RN; Gentles TL; Verrall C; du Plessis K; Celermajer DS; d'Udekem Y
    Int J Cardiol; 2017 Mar; 231():99-104. PubMed ID: 28100430
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transient elastography may identify Fontan patients with unfavorable hemodynamics and advanced hepatic fibrosis.
    Wu FM; Opotowsky AR; Raza R; Harney S; Ukomadu C; Landzberg MJ; Valente AM; Breitbart RE; Singh MN; Gauvreau K; Jonas MM
    Congenit Heart Dis; 2014; 9(5):438-47. PubMed ID: 24418160
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Imaging Assessment of Hepatic Changes after Fontan Surgery.
    Song J; Kim K; Huh J; Kang IS; Kim SH; Yang JH; Jun TG; Kim JH
    Int Heart J; 2018 Sep; 59(5):1008-1014. PubMed ID: 30158375
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fontan-Associated Liver Disease: Spectrum of Disease in Children and Adolescents.
    Rathgeber SL; Guttman OR; Lee AF; Voss C; Hemphill NM; Schreiber RA; Harris KC
    J Am Heart Assoc; 2020 Jan; 9(1):e012529. PubMed ID: 31902322
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Heart transplantation in Fontan patients across Australia and New Zealand.
    Shi WY; Yong MS; McGiffin DC; Jain P; Ruygrok PN; Marasco SF; Finucane K; Keogh A; d'Udekem Y; Weintraub RG; Konstantinov IE
    Heart; 2016 Jul; 102(14):1120-6. PubMed ID: 27000055
    [TBL] [Abstract][Full Text] [Related]  

  • 15. More than the heart: Hepatic, renal, and cardiac dysfunction in adult Fontan patients.
    Byrne RD; Weingarten AJ; Clark DE; Huang S; Perri RE; Scanga AE; Menachem JN; Markham LW; Frischhertz BP
    Congenit Heart Dis; 2019 Sep; 14(5):765-771. PubMed ID: 31282062
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term outcomes of warfarin versus aspirin after Fontan surgery.
    Attard C; Monagle PT; d'Udekem Y; Mackay MT; Briody J; Cordina R; Hassan EB; Simm P; Rice K; Ignjatovic V;
    J Thorac Cardiovasc Surg; 2021 Oct; 162(4):1218-1228.e3. PubMed ID: 33563422
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quality of Life and Well-Being in Adults With Fontan Physiology: Findings From the Australian and New Zealand Fontan Registry Quality of Life Study.
    Marshall KH; d'Udekem Y; Winlaw DS; Zannino D; Celermajer DS; Justo R; Iyengar A; Cordina R; Sholler GF; Woolfenden SR; Kasparian NA
    J Am Heart Assoc; 2024 Aug; 13(15):e033818. PubMed ID: 39011952
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatic Abnormalities Are Present Before and Early After the Fontan Operation.
    Schwartz MC; Glatz AC; Daniels K; Goldberg DJ; Rand E; Epelman MS; Cohen MS
    Ann Thorac Surg; 2015 Dec; 100(6):2298-304. PubMed ID: 26343976
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Redefining expectations of long-term survival after the Fontan procedure: twenty-five years of follow-up from the entire population of Australia and New Zealand.
    d'Udekem Y; Iyengar AJ; Galati JC; Forsdick V; Weintraub RG; Wheaton GR; Bullock A; Justo RN; Grigg LE; Sholler GF; Hope S; Radford DJ; Gentles TL; Celermajer DS; Winlaw DS
    Circulation; 2014 Sep; 130(11 Suppl 1):S32-8. PubMed ID: 25200053
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Abnormalities in liver function and coagulation profile following the Fontan procedure.
    van Nieuwenhuizen RC; Peters M; Lubbers LJ; Trip MD; Tijssen JG; Mulder BJ
    Heart; 1999 Jul; 82(1):40-6. PubMed ID: 10377307
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.